Search
for

    Sort by

    Research 61–90 of 1000+

    1. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    2. Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia 2011
    3. Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review Journal of Clinical Medicine · 2021 · 34 citations
    4. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Human Genomics · 2024 · 1 citations
    5. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    6. Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved] Faculty of 1000 Research Ltd · 2015
    7. Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori National Repository of Dissertations in Serbia · 2016
    8. Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens Metas de Enfermería · 2005
    9. Expression and Cellular Localization of Keratinocyte Growth Factor and Its Receptor in Human Hyperplastic Prostate Tissue<sup>1</sup> The Journal of Clinical Endocrinology & Metabolism · 1998 · 4 citations
    10. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia Translational Andrology and Urology · 2019 · 110 citations
    11. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I Mayo Clinic Proceedings · 2006 · 2 citations
    12. 5α‐Reductase Isozymes and Androgen Actions in the Prostate Annals of the New York Academy of Sciences · 2009 · 93 citations
    13. Association between prostate‐specific antigen and serum testosterone: A systematic review and meta‐analysis Andrology · 2020 · 11 citations
    14. Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa Maturitas · 2006 · 7 citations
    15. Diseases of the Canine Prostate Gland Veterinary medicine and science · 2022 · 1 citations
    16. Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy 2011 · 39 citations
    17. Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results Animals · 2024 · 4 citations
    18. Regarding prostate-specific antigen: let's not shoot the messenger QJM · 2011 · 3 citations
    19. Effect of finasteride on prostate-specific antigen Lancet Oncology · 2006 · 2 citations
    20. Hiperplasia quística prostática en un perro joven: reporte de caso MQRInvestigar · 2023
    21. IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER The Journal of Urology · 2009
    22. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    23. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2005
    24. Alcohol and Prostate Cancer: Time to Draw Conclusions Biomolecules · 2022 · 9 citations
    25. Association between male pattern baldness and prostate disease: A meta-analysis Urologic Oncology: Seminars and Original Investigations · 2017 · 7 citations
    26. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    27. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial British Journal of Cancer · 2009 · 49 citations
    28. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2004 · 33 citations
    29. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    30. Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-β-induced prostate stromal cells (WPMY-1) proliferation via PI3K/AKT signaling pathway Frontiers in Pharmacology · 2024 · 3 citations